Dr. John Cheatham is Director of Cardiac Catheterization and Interventional Therapy at The Heart Center of Nationwide Children's Hospital, and Clinical Professor of Pediatrics and Internal Medicine at The Ohio State University College of Medicine and Public Health. He is a senior member of The Heart Center and serves as a consultant and proctor to various medical companies inside and outside of the United States dedicated to the transcatheter therapy of congenital heart disease. Dr. Cheatham’s interests and expertise are in the transcatheter treatment of newborns, children and young adults with congenital heart disease. He has pioneered several new techniques in nonsurgical therapy. Dr. Cheatham has served as a principal investigator in seven FDA clinical trials evaluating nonsurgical closure devices during the past year, including muscular, high-risk muscular, and membranous ventricular septal defect, large atrial septal defect, patent ductus arteriosus, and patent foramen ovale, as well as numerous other FDA clinical trials over the past 12 years. He is also establishing a cardiac catheterization research laboratory to investigate future treatment options for children born with congenital heart disease. |